Logo Image
In Brief
Spotlight

GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial

GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.

Latest news

Boehringer and CDR-Life report data from geographic atrophy treatment trial

Preparation for the Phase II trial is underway, with a planned start date earlier next year.

Plan for success and prepare for adversity – Clinical Trial Supply West Coast 2024

The upcoming Clinical Trial Supply West Coast 2024 conference will explore the most important topics impacting clinical trial supply operations and technology leaders.

Tempo doses first patient with tissue scaffolds in cancer surgery trial

The company received financial backing for trialling the surgical scaffolding product from J&J’s venture capital arm.

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial

The study is sponsored and being carried out by The University of Texas MD Anderson Cancer Center in the US.

Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases

Results from the study are expected in the first half of next year.

Lilly’s efsitora shows promise in Phase III type 2 diabetes trials

Efsitora alfa demonstrated to offer similar A1C reduction compared to daily insulin in two clinical trials.

As mpox spreads, ‘national governments have a moral responsibility to help’

Representatives of the WHO and the IFRC called for international cooperation to tackle the current mpox outbreak.